CSIMarket Company Name, Ticker, Suppliers, else..


Cullinan Therapeutics Inc   (NASDAQ: CGEM)
Other Ticker:  
 

Cullinan Therapeutics Inc

CGEM's Fundamental analysis



Cullinan Therapeutics Inc 's sales fell in III. Quarter 2024 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 13.29 %

Cullinan Therapeutics Inc net loss increased from $-39 millions, to $-41 millions in III. Quarter 2024,

• More on CGEM's Growth


Cullinan Therapeutics Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 19.61 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.38.


• More on CGEM's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 10.76

Cullinan Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 19.61 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.38.

Cullinan Therapeutics Inc Price to Book Ratio is at 1.16 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.01

• More on CGEM's Valuation

•  Market Capitalization (Millions $) 730
•  Shares Outstanding (Millions) 58
•  Employees 2
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -145
•  Cash Flow (TTM) (Millions $) 37
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 10.76

•  Market Capitalization (Millions $) 730
•  Shares Outstanding (Millions) 58
•  Employees 2
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -145
•  Cash Flow (TTM) (Millions $) 37
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 25.8
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.04
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com